- Home
- VOXX vs LRMR Comparison
VOXX vs LRMR Comparison
Compare VOXX & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOXX
- LRMR
- Stock Information
- Founded
- VOXX 1960
- LRMR N/A
- Country
- VOXX United States
- LRMR United States
- Employees
- VOXX N/A
- LRMR N/A
- Industry
- VOXX Electronic Components
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- VOXX Technology
- LRMR Health Care
- Exchange
- VOXX Nasdaq
- LRMR Nasdaq
- Market Cap
- VOXX 169.1M
- LRMR 183.8M
- IPO Year
- VOXX 1987
- LRMR N/A
- Fundamental
- Price
- VOXX $7.50
- LRMR $2.15
- Analyst Decision
- VOXX
- LRMR Strong Buy
- Analyst Count
- VOXX 0
- LRMR 10
- Target Price
- VOXX N/A
- LRMR $19.60
- AVG Volume (30 Days)
- VOXX 179.3K
- LRMR 911.3K
- Earning Date
- VOXX 05-13-2025
- LRMR 03-24-2025
- Dividend Yield
- VOXX N/A
- LRMR N/A
- EPS Growth
- VOXX N/A
- LRMR N/A
- EPS
- VOXX N/A
- LRMR N/A
- Revenue
- VOXX $397,407,000.00
- LRMR N/A
- Revenue This Year
- VOXX $7.88
- LRMR N/A
- Revenue Next Year
- VOXX $7.24
- LRMR N/A
- P/E Ratio
- VOXX N/A
- LRMR N/A
- Revenue Growth
- VOXX N/A
- LRMR N/A
- 52 Week Low
- VOXX $2.27
- LRMR $2.07
- 52 Week High
- VOXX $8.40
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- VOXX 60.64
- LRMR 32.88
- Support Level
- VOXX $7.43
- LRMR $2.19
- Resistance Level
- VOXX $7.51
- LRMR $2.44
- Average True Range (ATR)
- VOXX 0.02
- LRMR 0.18
- MACD
- VOXX -0.00
- LRMR -0.00
- Stochastic Oscillator
- VOXX 75.00
- LRMR 11.11
About VOXX VOXX International Corporation
VOXX International Corp manufacturer and distributor in the Automotive Electronics, Consumer Electronics, and Biometrics industries. The consumer electronic products primarily consist of finished goods sold to retail and commercial customers, consisting of premium audio and other consumer electronic products. Automotive products, some of which are manufactured by the Company, are sold both to OEM and aftermarket customers. Biometric products, primarily consisting of finished goods, are sold to retail and commercial customers.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.